Imvax, Inc. is set to highlight its innovative research on glioblastoma treatment at the 2024 Society for NeuroOncology (SNO) ...

My lovely daughter, Ruth, is going to run a marathon. The training is proving difficult, but she is keen to raise money for ...

In 2016, cancer biologist Johanna Joyce of the Memorial Sloan Kettering Cancer Center published a study in Science that ...

Filippo Veglia, Ph.D., of Wistar’s Genome Regulation and Cell Signaling Program, discusses the most lethal form of brain ...

Two years ago, Paul Chappell was diagnosed with a rare brain tumor.Now, he's at risk of losing the insurance and care that ...

When we talk about cancer, the ones related to breasts, lungs, and skin often top the list. But glioblastoma, also known as glioblastoma multiforme, should not be ignored. It is a rare tumour with ...

A man stayed awake during an eight-hour operation on his brain - and played the guitar. Colin Miller, 64, strummed chords on ...

CAR T-cell therapy shows promise for solid tumors like glioblastoma. New engineering strategies and clinical trial results ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

Trials with mice in whom the researchers implanted human glioblastoma cells have already shown that the treatment is very ...

Alpha DaRT® accepted into the prestigious Total Product Life Cycle Advisory Program (TAP) of the FDA, to accelerate market access to the Alpha ...

Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty ...